Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

Aditya Khemka, Fund Manager at InCred Asset Management, remains cautious about Indian companies looking to manufacture GLP-1 ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...

Obesity is linked to lower steroid-free clinical remission rates in patients with inflammatory bowel disease, a recent study ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more ...

Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

What is our current understanding of how differences in sex can affect obesity prevalence, comorbidities, and treatment ...